Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G for Beta Bionics, Inc. Common Stock (BBNX).
- Disclosed ownership: 6.8%.
- Date of event: 30 Jun 2025.
MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G Report for Beta Bionics, Inc. Common Stock (BBNX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- Beta Bionics, Inc. Common Stock
- Symbol
- BBNX
- Shares outstanding
- 43,071,147 shares
- Disclosed Ownership
- 2,928,838 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Aug 2025, 15:20:42 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 6.8% ownership in Beta Bionics, Inc. Common Stock (BBNX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Aug 2025, 15:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 6.8% | 2,928,838 | 0 | 2,927,593 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 6.7% | 2,899,502 | 0 | 2,899,502 | Christopher O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |